Literature DB >> 34138968

Correction: Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.

Gianluigi Giannelli, Armando Santoro, Robin K Kelley, Ed Gane, Valerie Paradis, Ann Cleverly, Claire Smith, Shawn T Estrem, Michael Man, Shuaicheng Wang, Michael M Lahn, Eric Raymond, Karim A Benhadji, Sandrine Faivre.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0222259.].

Entities:  

Year:  2021        PMID： 34138968      PMCID： PMC8211152          DOI： 10.1371/journal.pone.0253671

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


There is an error in affiliation 2 for the second author Armando Santoro. The correct affiliation 2 is: Humanitas Clinical and Research Center–IRCCS, Humanitas Cancer Center, Milan, Italy. An additional affiliation is also missing for the second author. Armando Santoro is also affiliated with Humanitas University, Department of Biomedical Sciences, Milan, Italy.
  1 in total

1.  Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF-βRI inhibitor galunisertib.

Authors:  Gianluigi Giannelli; Armando Santoro; Robin K Kelley; Ed Gane; Valerie Paradis; Ann Cleverly; Claire Smith; Shawn T Estrem; Michael Man; Shuaicheng Wang; Michael M Lahn; Eric Raymond; Karim A Benhadji; Sandrine Faivre
Journal:  PLoS One       Date:  2020-03-25       Impact factor: 3.240
  1 in total
  1 in total

Review 1.  Neuropilin (NRPs) Related Pathological Conditions and Their Modulators.

Authors:  Matic Broz; Anja Kolarič; Marko Jukič; Urban Bren
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.